Calcium l-aspartate

Base Information

• Chemical Name: Calcium l-aspartate
• CAS No.: 10389-09-0
• Molecular Formula: C4H5CaNO4
• Molecular Weight: 171.17
• European Community (EC) Number: 244-185-8,600-502-5
• UNII: T9680JD4IY
• DSSTox Substance ID: DTXSID60908654
• Nikkaji Number: J62.327J
• Wikidata: Q27114279
• NCI Thesaurus Code: C87332
• ChEMBL ID: CHEMBL2106115
• Mol file: 10389-09-0.mol

Synonyms:(+-)-Aspartic Acid;(R,S)-Aspartic Acid;Ammonium Aspartate;Aspartate;Aspartate Magnesium Hydrochloride;Aspartate, Ammonium;Aspartate, Calcium;Aspartate, Dipotassium;Aspartate, Disodium;Aspartate, Magnesium;Aspartate, Monopotassium;Aspartate, Monosodium;Aspartate, Potassium;Aspartate, Sodium;Aspartic Acid;Aspartic Acid, Ammonium Salt;Aspartic Acid, Calcium Salt;Aspartic Acid, Dipotassium Salt;Aspartic Acid, Disodium Salt;Aspartic Acid, Hydrobromide;Aspartic Acid, Hydrochloride;Aspartic Acid, Magnesium (1:1) Salt, Hydrochloride, Trihydrate;Aspartic Acid, Magnesium (2:1) Salt;Aspartic Acid, Magnesium-Potassium (2:1:2) Salt;Aspartic Acid, Monopotassium Salt;Aspartic Acid, Monosodium Salt;Aspartic Acid, Potassium Salt;Aspartic Acid, Sodium Salt;Calcium Aspartate;Dipotassium Aspartate;Disodium Aspartate;L Aspartate;L Aspartic Acid;L-Aspartate;L-Aspartic Acid;Magnesiocard;Magnesium Aspartate;Mg-5-Longoral;Monopotassium Aspartate;Monosodium Aspartate;Potassium Aspartate;Sodium Aspartate

Chemical Property of Calcium l-aspartate

Chemical Property:

• PSA: 78.62000
• LogP: -0.58090
• Hydrogen Bond Donor Count: 1
• Hydrogen Bond Acceptor Count: 5
• Rotatable Bond Count: 1
• Exact Mass: 170.9844485
• Heavy Atom Count: 10
• Complexity: 122

Purity/Quality:

99.9% ^*data from raw suppliers

Asparticacidcalcium >98.0% ^*data from reagent suppliers

Safty Information:

• Pictogram(s):  
• Hazard Codes: 

MSDS Files:

SDS file from LookChem

Useful:

• Canonical SMILES: C(C(C(=O)[O-])N)C(=O)[O-].[Ca+2]
• Isomeric SMILES: C([C@@H](C(=O)[O-])N)C(=O)[O-].[Ca+2]
• Recent NIPH Clinical Trials: A multi-facility collaborative controlled trial of the effects of teriparatide on bone union in fragility fractures of patients with osteoporosis (exploratory research)